Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
U.S. judge will allow J&J to contest science in talc litigation
A U.S. judge will allow Johnson & Johnson to contest scientific findings which link its baby powder to ovarian cancer.
Kevin Dunleavy
Mar 28, 2024 12:52pm
Regulatory tracker: Keytruda wins EU nod in perioperative NSCLC
Mar 28, 2024 11:20am
Sponsored
BioDesign: Accelerating the Momentum of Bioconjugate Therapeutics
Mar 25, 2024 8:00am
WuXi AppTec allegedly handed over client's IP to China: report
Mar 28, 2024 10:21am
Sponsored
The biopharma “brain drain”: Finding talent to fuel innovation
Jan 26, 2024 8:00am
Akebia's Vafseo wins FDA approval 2 years after rejection
Mar 28, 2024 9:25am